Axovia Therapeutics is a startup based in the United Kingdom.
Based in the United Kingdom, Axovia Therapeutics is a startup.
Axovia Therapeutics is developing gene therapies using AAV9 vectors to treat genetic ciliopathies, including Bardet-Biedl Syndrome, aiming to prevent blindness and reverse obesity caused by mutations in the BBS1 gene.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.